Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • P1118: LONGER FOLLOW-UP FROM T...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

Bibliographic Details
Published in:HemaSphere
Main Authors: Wojciech Jurczak, Herve Ghesquieres, Yasmin Karimi, Chan Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, David Lewis, Robin Gasiorowski, Tae Min Kim, Marjolein Van Der Poel, Michelle Limei Poon, Tatyana Feldman, Kim Linton, Anna Sureda, Martin Hutchings, Salim Kanoun, Laetitia Vercellino, Mariana Cota Stirner, Stephanie Mcgoldrick, Yan Liu, Mariana Sacchi, Pieternella Lugtenburg, Catherine Thieblemont
Format: Article
Language:English
Published: Wiley 2023-08-01
Online Access:http://journals.lww.com/10.1097/01.HS9.0000971368.08106.5c
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000971368.08106.5c

Similar Items

  • C012 | NOVEL ANALYSIS OF RESULTS FROM THE PIVOTAL EPCORE NHL-1 STUDY: OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AND COMPLETE RESPONSE AT 2-YEARS WITH EPCORITAMAB MONOTHERAPY
    by: P.L. Zinzani, et al.
    Published: (2025-09-01)
  • DP015 | EPCORITAMAB + R-ICE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION: EPCORE NHL-2
    by: G. Musuraca, et al.
    Published: (2025-09-01)
  • DP008 | EPCORE DLBCL-3: FIXED-DURATION EPCORITAMAB MONOTHERAPY IN OLDER (≥75 Y), ANTHRACYCLINE-INELIGIBLE PATIENTS WITH PREVIOUSLY UNTREATED LARGE B-CELL LYMPHOMA
    by: U. Vitolo, et al.
    Published: (2025-09-01)
  • P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE
    by: Michael Roost Clausen, et al.
    Published: (2023-08-01)
  • DP074 | EPCORITAMAB MONOTHERAPY DEMONSTRATES DEEP AND DURABLE RESPONSES AT 3-YEAR FOLLOW-UP IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
    by: M. Frascione, et al.
    Published: (2025-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs